Spanish Professional Services Stock News

BME:GRF
BME:GRFBiotechs

Is Grifols (BME:GRF) Pricing Reflect Recent Governance Concerns Or A Longer Term Opportunity?

Wondering whether Grifols at around €9.16 a share is offering genuine value or just looks cheap on the surface? This article walks through what the current price might actually be telling you. The stock has returned 2.2% over the last week and 1.2% over the last month, while the year to date return sits at an 18.2% decline and the 1 year return is 13.3%, set against a 16.1% decline over 3 years and a 59.8% decline over 5 years. Recent headlines around Grifols have focused on its balance...
BME:ELE
BME:ELEElectric Utilities

Endesa (BME:ELE) EPS Jump To €0.70 Challenges Cautious Growth Narratives

Endesa (BME:ELE) opened Q1 2026 with revenue of €5.8b and basic EPS of €0.70, setting the tone for how investors will read the latest move in profitability. The company reported quarterly revenue of €5.8b in both Q1 2025 and Q1 2026, while EPS increased from €0.55 to €0.70 over the same period, providing a clearer view of how earnings are tracking against a broadly stable top line. With trailing net margins above last year and earnings growth running ahead of revenue, this update places...
BME:ROVI
BME:ROVIPharmaceuticals

Rovi (BME:ROVI) Margin Strength In Q4 EPS Beat Tests Bearish CDMO Narrative

Laboratorios Farmaceuticos Rovi (BME:ROVI) has capped FY 2025 with fourth quarter revenue of €218.4 million and basic EPS of €0.83, while trailing 12 month figures show revenue of €743.5 million and EPS of €2.75 alongside net income of €140.4 million. The company has seen quarterly revenue move from €199.1 million in Q4 2024 to €218.4 million in Q4 2025, with net income rising over the same period from €23.4 million to €42.7 million, setting up a story where margins and earnings power sit...
BME:YGMP
BME:YGMPREITs

GMP Property SOCIMI (BME:YGMP) One Off Gain Challenges Earnings Quality Narratives

Earnings snapshot and context GMP Property SOCIMI (BME:YGMP) has released its H1 2025 figures, reporting total revenue of €57.2 million and basic EPS of €5.97, alongside a very large 12‑month profit swing that management attributes in part to a €138.0 million one‑off gain. Over recent half‑year periods, the company reported revenue of €49.2 million and EPS of €3.74 in H1 2024, compared with €57.2 million and EPS of €5.97 in H1 2025, while H2 2023 revenue was €49.8 million with an EPS loss of...
BME:EBRO
BME:EBROFood

Ebro Foods (BME:EBRO) Valuation Check After Q1 Profit Growth And Softer Sales

Q1 earnings snapshot and why it matters for Ebro Foods (BME:EBRO) Ebro Foods (BME:EBRO) opened the year with first quarter sales of €755.48 million versus €791.96 million a year earlier, while net income reached €52.95 million compared with €50.3 million. This combination may reshape how you think about the stock. See our latest analysis for Ebro Foods. The share price sits at €18.28, with a 30 day share price return of a 2.66% decline and a year to date share price return of a 0.98% decline...
BME:FCC
BME:FCCCommercial Services

A Look At Fomento de Construcciones y Contratas (BME:FCC) Valuation After Its Q1 2026 Earnings Call

The Q1 2026 earnings call for Fomento de Construcciones y Contratas (BME:FCC) on April 30 has put fresh attention on the stock, as investors reassess recent returns alongside the company’s latest operating update. See our latest analysis for Fomento de Construcciones y Contratas. The Q1 2026 earnings call appears to have been a key catalyst for the recent move, with the 1 day share price return of 1.63% and 7 day share price return of 2.00% helping the stock edge higher. The 1 year total...
BME:VIS
BME:VISFood

Viscofan (BME:VIS) Valuation Check After Q1 2026 Earnings Resilience

First quarter results and why they matter for Viscofan (BME:VIS) shareholders Viscofan (BME:VIS) has just reported first quarter 2026 results, with sales of €305.33 million versus €307.64 million a year earlier, while net income came in at €33.68 million compared with €31.36 million. See our latest analysis for Viscofan. The first quarter update comes after a steady share price run, with a 90 day share price return of 8.59% and a 12.83% year to date share price return from the current €60.7...
BME:SCYR
BME:SCYRConstruction

Assessing Sacyr (BME:SCYR) Valuation After Stronger Q1 Results And Remote Shareholders Meeting News

Sacyr (BME:SCYR) is in focus after its board met on April 28, 2026 to prepare a fully remote ordinary shareholders meeting and the company released first quarter 2026 results showing higher revenue and net income year on year. See our latest analysis for Sacyr. The recent first quarter results and news of a fully remote shareholders meeting come as Sacyr's share price has shown firm positive momentum, with a 30 day share price return of 9.33% and a 1 year total shareholder return of 50.75%,...
BME:IDR
BME:IDRIT

High Growth Tech Stocks in Europe with Promising Potential

The European market has shown mixed performance recently, with the pan-European STOXX Europe 600 Index ending the week slightly up amid positive earnings momentum but tempered by geopolitical tensions and rising oil prices. As investors navigate these uncertain conditions, identifying high-growth tech stocks in Europe involves looking for companies that demonstrate resilience and adaptability in a fluctuating economic environment.
BME:PSG
BME:PSGCommercial Services

Prosegur (BME:PSG) Margin Improvement To 2.5% Tests Bullish Profitability Narrative

Prosegur Compañía de Seguridad (BME:PSG) opened 2026 with Q1 revenue of €1.3b and net income of €33m, against a backdrop of trailing 12 month revenue of about €4.9b and net income of €124.3m that has been growing faster than the top line. The company has seen quarterly revenue move from €1.32b in Q4 2024 to €1.25b in Q1 2025 and €1.27b in Q1 2026, while trailing 12 month net income has risen from €78.1m to €124.3m. This sets up a story where expanding margins and higher earnings do more of...
BME:SAN
BME:SANBanks

Assessing Banco Santander (BME:SAN) Valuation After Strong Recent Share Price Momentum

Banco Santander stock: key context for investors Banco Santander (BME:SAN) is drawing attention after recent trading, with the stock showing a month return of 7.89% and a past 3 months return of 1.17%, prompting closer scrutiny of its valuation and fundamentals. See our latest analysis for Banco Santander. The recent 4.09% 1 day share price return and 7.89% 1 month share price return at €10.588 come after a much stronger backdrop, with 1 year total shareholder return of 70.11% and very large...
BME:CASH
BME:CASHCommercial Services

Prosegur Cash (BME:CASH) Net Margin Reaches 4.5% Testing Slowdown Concerns

Prosegur Cash's Q1 2026 earnings in focus Prosegur Cash (BME:CASH) has followed up its Q1 2026 results with a recent run of quarterly numbers that show revenue between €483.1 million and €516.1 million and basic EPS ranging from €0.00974 to €0.035984 over 2025, while trailing twelve month EPS at Q4 2025 sat at €0.061479 on €1.99 billion of revenue. Over the past year, the company has seen trailing twelve month revenue move between €1.89 billion and €2.14 billion, with EPS over that same basis...
BME:CABK
BME:CABKBanks

CaixaBank (BME:CABK) Valuation Check After Q1 Net Income Climbs To €1,572 Million

Q1 earnings set fresh context for CaixaBank stock CaixaBank (BME:CABK) opened its 2026 story with first quarter net income of €1,572 million, compared with €1,470 million a year earlier. This result gives investors fresh data to reassess the stock. See our latest analysis for CaixaBank. The Q1 earnings update lands at a time when the stock is trading at €10.79, with a 1 month share price return of 3.95% and a 1 year total shareholder return of 61.50%. The 3 year total shareholder return is...
BME:SAB
BME:SABBanks

Sabadell (BME:SAB) Net Margin Slip To 28.3% Tests Bullish Profitability Narrative

Banco de Sabadell (BME:SAB) has opened Q1 2026 earnings season with Q4 2025 revenue of about €1.4b and net income of €386m, translating into basic EPS of €0.08 and a trailing twelve month EPS of €0.24. Over recent quarters, revenue has moved between €1.4b and €1.5b while quarterly EPS has ranged from €0.08 to €0.09, setting the backdrop for a trailing net margin of 28.3% compared with 31.2% a year earlier. For investors, this mix of steady top line, solid profitability levels and slightly...
BME:BBVA
BME:BBVABanks

A Look At BBVA (BME:BBVA) Valuation After Strong Q1 2026 Results And Buyback Expansion

Banco Bilbao Vizcaya Argentaria (BME:BBVA) has drawn fresh attention after reporting first quarter 2026 net income of €2,989 million and net interest income of €7,560 million, alongside an additional multi billion euro share buyback tranche. See our latest analysis for Banco Bilbao Vizcaya Argentaria. The share price reaction has been mixed, with a 1 day share price return of 1.81% and a recent bounce on the Q1 update and buyback news, set against a 90 day share price return of a 14.15%...
BME:CIE
BME:CIEAuto Components

How Investors May Respond To CIE Automotive (BME:CIE) AGM Approvals, Dividend And Subsidiary Merger

CIE Automotive India’s 27th AGM, held on 29 April 2026, saw shareholders approve all eight resolutions, including a ₹7 per share dividend, major related-party transaction limits with Mahindra & Mahindra and CIE Automotive S.A., and the merger of wholly owned subsidiary CIE Aluminium Casting India Limited. The clean audit reports, unanimous voting outcomes, and disclosure of robust quarterly operational results collectively point to solid governance, business alignment with key partners, and...
BME:SAN
BME:SANBanks

Has Santander (BME:SAN) Run Too Far After Its 67% One Year Share Price Surge?

Investors may be asking whether Banco Santander at €10.38 is still offering value after a strong run, or whether much of the easier upside has already been realized. The share price performance has been strong, with returns of 1.8% over the past week, 5.8% over the past month, 1.2% year to date and 67.1% over the last year. The 3-year and 5-year returns stand at 259.4% and 273.6% respectively. Recent coverage has focused on Banco Santander's position within the European banking sector and...
BME:IDR
BME:IDRIT

Indra Sistemas (BME:IDR) Valuation Check After Q1 2026 Revenue Growth And Reaffirmed Guidance

Indra Sistemas (BME:IDR) drew attention after Q1 2026 results showed 15% revenue growth, a miss versus analyst expectations, and pre market weakness, while management reaffirmed full year revenue and EBIT targets. See our latest analysis for Indra Sistemas. At a share price of €48.81, the stock has seen a 2.4% 7 day share price return but a 10.6% 90 day share price decline, while the 1 year total shareholder return of 67.7% and very large 5 year total shareholder return suggest earlier...
BME:AENA
BME:AENAInfrastructure

A Look At Aena S.M.E (BME:AENA) Valuation After Strong Q1 2026 Earnings Update

Earnings snapshot and what just changed Aena S.M.E (BME:AENA) just released its Q1 2026 results, reporting sales of €1,469.32m and net income of €329.42m, compared with €1,309.88m and €301.31m a year earlier. Basic and diluted earnings per share from continuing operations were €0.22, compared with €0.20 in the same period last year. This gives investors fresh data to reassess the stock after a weak past 3 months. See our latest analysis for Aena S.M.E. The Q1 report arrives after a weaker...
BME:ANA
BME:ANAElectric Utilities

Assessing Acciona (BME:ANA) Valuation After New US Infrastructure Win On Georgia’s State Route 400

US infrastructure win puts Acciona (BME:ANA) in focus Acciona (BME:ANA) has come into focus after its construction arm, within the FlatironDragados consortium, was chosen to help build tolled express lanes on Georgia’s State Route 400 under a public private partnership. The project, backed by government loans and private activity bonds, adds another reference contract to Acciona’s international infrastructure portfolio. This portfolio spans roads, water solutions, renewable energy assets, and...